trending Market Intelligence /marketintelligence/en/news-insights/trending/IYmY5vNMS7oqgj4KqJf5dg2 content esgSubNav
In This List

Proteostasis CFO resigns

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Proteostasis CFO resigns

Proteostasis Therapeutics Inc. CFO James DeTore will leave the company, effective Feb. 10, for personal reasons.

Brett Hagen, the company's controller and principal accounting officer, will assume certain of DeTore's duties on an interim basis, while Proteostasis searches for a permanent CFO.

Hagen previously served as a controller for BIND Therapeutics Inc.